Adia Med Completes Phase 1 and Formally Launches Phase 2 of Autism Spectrum Disorder Clinical Study
Next Cohort of 30 Children to Begin a New Phase 1 Treatment Group on October 1, 2026, as Successive Enrollment...
Next Cohort of 30 Children to Begin a New Phase 1 Treatment Group on October 1, 2026, as Successive Enrollment...
PALO ALTO, CA / ACCESS Newswire / July 29, 2026 / Bioz, Inc., the world's most advanced platform that aids...
Record Fiscal Year Net Revenue of $915 Million, Record Gross Profit, Consistent Adjusted Gross Margin3 and Record Adjusted EBITDA5 Highlights the...
WATERTOWN, Mass., July 28, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new...
Mechelen, Belgium; July 28, 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9,...
MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader...
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), today announced that the...
OXFORD, Miss. and CANTON, Miss., July 28, 2026 (GLOBE NEWSWIRE) -- The National Center for Cannabis Research and Education (NCCRE)...
LOS ANGELES, July 28, 2026 (GLOBE NEWSWIRE) -- The Cooperative of American Physicians, Inc. (CAP), a leading provider of medical...
New research indicates attention on laboratory modernization. As the Association for Diagnostics and Laboratory Medicine 2026 Annual Scientific Meeting and...
EAGLE, Idaho, July 28, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries...
BERWYN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- AscellaHealth, a full-spectrum pharmacy solutions provider rooted in specialty pharmacy expertise, today...
Consolidated net revenue of € 1,410.8 million in the first half of 2026, +6.6% or +9.1% on a like-for-like basis(3)...
Solid revenue1 trajectory at +9.7% in H1, with Q2 at +8.7% Increasing profitability, with Adj. Operating Profit1,2 +15% Group’s revenue...
FIRST HALF OF 2026, CONTINUATION OF THE STRATEGIC TRANSFORMATION First-half revenue up 5% to €84.5 millionContinuation of the Group’s strategy:...
Recognition spans five procedure categories, including breast augmentation, liposuction, rhinoplasty, eyelid surgery and tummy tuckSOUTHLAKE, Texas, July 28, 2026 (GLOBE...
SodaSlim Gummies expand the company’s product portfolio following a coordinated development cycle covering formulation design, production planning, packaging preparation and...
Alliance’s Never Too Young Taskforce Tackles Growing Crisis as Cases of the Deadliest Cancer Continue to Rise in People Under...
SCOTTSDALE, Ariz., July 28, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases...
Financial Management Veteran Says He’s Excited to Join ‘Rock Stars of Medical Device Distribution’DALLAS, July 28, 2026 (GLOBE NEWSWIRE) --...